Watchlist Price Alert

Theravance Biopharma Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

10.71

0.10 (0.94%)

At close: Jun 13, 2025, 3:59 PM

10.69

-0.19%

After-hours: Jun 13, 2025, 05:50 PM EDT

Theravance Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	64.38M	57.42M	51.35M	55.31M	71.86M	73.41M	60.37M	15.39M	48.65M
Cost of Revenue	n/a	n/a	6.59M	7.29M	260.95M	219.25M	715K	6.03M	2.89M
Gross Profit	64.38M	57.42M	44.76M	48.02M	-189.1M	-145.83M	59.66M	9.36M	45.75M
Operating Income	-46.95M	-56.03M	-91.96M	-257.78M	-297.76M	-251.91M	-238.75M	-260.12M	-180.47M
Interest Income	4.88M	9.12M	8.54M	1.11M	2.83M	8.39M	11.97M	4.96M	1.31M
Pretax Income	-44.61M	-49.27M	-92.81M	-199.58M	-286.54M	-241.68M	-226.09M	-271.71M	-180.56M
Net Income	-56.42M	-55.19M	-92.82M	-199.43M	-278.02M	-236.46M	-215.52M	-285.4M	-190.67M
Selling & General & Admin	69.17M	70.09M	67.07M	99.3M	108.66M	106.08M	97.06M	95.59M	84.51M
Research & Development	37.64M	40.62M	63.39M	193.66M	260.95M	219.25M	201.35M	173.89M	141.71M
Other Expenses	4.51M	2.74M	n/a	n/a	-1.61M	n/a	n/a	n/a	n/a
Operating Expenses	111.33M	113.46M	130.47M	292.95M	369.61M	325.33M	298.41M	269.48M	226.22M
Interest Expense	2.55M	2.35M	6.37M	46.89M	44.59M	31.86M	10.48M	8.55M	1.4M
Selling & Marketing Expenses	n/a	n/a	8M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	111.33M	113.46M	130.47M	292.95M	369.61M	325.33M	299.12M	275.51M	229.12M
Income Tax Expense	11.8M	5.92M	9K	-151K	-8.52M	-5.22M	-10.56M	13.69M	10.11M
Shares Outstanding (Basic)	48.85M	55.3M	73.59M	69.46M	62.34M	55.61M	53.97M	52.35M	44.71M
Shares Outstanding (Diluted)	48.85M	55.3M	73.59M	69.46M	62.34M	55.61M	53.97M	52.35M	44.71M
EPS (Basic)	-1.15	-1	-1.26	-2.87	-4.46	-4.25	-3.99	-5.45	-4.26
EPS (Diluted)	-1.15	-1	-1.26	-2.87	-4.46	-4.25	-3.99	-5.45	-4.26
EBITDA	-38.45M	-42.66M	-79.86M	-249.39M	-294M	-203.29M	-212.44M	-259.14M	-176.04M
EBIT	-42.07M	-46.92M	-86.45M	-256.68M	-294.8M	-209.81M	-215.6M	-263.16M	-179.16M
Depreciation & Amortization	3.62M	4.26M	6.59M	7.29M	6.64M	6.52M	3.17M	4.03M	3.12M